Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis Spuls

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Trials|February 18, 2025
Correction: The UPDATE trial (UVB Phototherapy in Dermatology for Atopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczemaEva Knöps, Phyllis Spuls, Ruben Duijnhoven, et al.
Trials|July 16, 2024
The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczemaEva Knöps, Phyllis Spuls, Ruben Duijnhoven, et al.
The Journal of Investigative Dermatology|November 22, 2023
Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic-Pharmacodynamic ModelingAstrid van Huizen, Paul Bank, Gayle van der Kraaij, et al.
BMJ Open|June 30, 2020
Generic outcome set for the international registry on Laser trEAtments in Dermatology (LEAD): a protocol for a Delphi study to achieve consensus on <i>what</i> to measureFrederike Fransen, Phyllis Spuls, Murad Alam, et al.
The Journal of Investigative Dermatology|March 11, 2022
Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis: First-Year Results of a Single-Blind Randomized Controlled TrialGayle van der Kraaij, Celine Busard, Juul van den Reek, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 13, 2023
Treat-to-target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitisYael Renert-Yuval, Ester Del Duca, Bernd Arents, et al.
Pigment Cell & Melanoma Research|February 5, 2026
Defining Important Aspects of Repigmentation in Vitiligo: Insights From Patients' PerspectivesJolien Duponselle, Marlide R Jukema, Nicoline van Buchem-Post, et al.
The Journal of Dermatological Treatment|October 10, 2025
Assessment of vitiligo in clinical practice: a cross-sectional survey among expertsJolien Duponselle, Marlide R Jukema, Albert Wolkerstorfer, et al.
Clinics in Dermatology|September 14, 2021
Learning from disease registries during a pandemic: Moving toward an international federation of patient registriesDmitri Wall, Raed Alhusayen, Bernd Arents, et al.
The Journal of Allergy and Clinical Immunology|October 19, 2020
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based studySatveer K Mahil, Nick Dand, Kayleigh J Mason, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Trials|February 18, 2025
Correction: The UPDATE trial (UVB Phototherapy in Dermatology for Atopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczemaEva Knöps, Phyllis Spuls, Ruben Duijnhoven, et al.
Trials|July 16, 2024
The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczemaEva Knöps, Phyllis Spuls, Ruben Duijnhoven, et al.
The Journal of Investigative Dermatology|November 22, 2023
Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic-Pharmacodynamic ModelingAstrid van Huizen, Paul Bank, Gayle van der Kraaij, et al.
BMJ Open|June 30, 2020
Generic outcome set for the international registry on Laser trEAtments in Dermatology (LEAD): a protocol for a Delphi study to achieve consensus on <i>what</i> to measureFrederike Fransen, Phyllis Spuls, Murad Alam, et al.
The Journal of Investigative Dermatology|March 11, 2022
Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis: First-Year Results of a Single-Blind Randomized Controlled TrialGayle van der Kraaij, Celine Busard, Juul van den Reek, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 13, 2023
Treat-to-target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitisYael Renert-Yuval, Ester Del Duca, Bernd Arents, et al.
Pigment Cell & Melanoma Research|February 5, 2026
Defining Important Aspects of Repigmentation in Vitiligo: Insights From Patients' PerspectivesJolien Duponselle, Marlide R Jukema, Nicoline van Buchem-Post, et al.
The Journal of Dermatological Treatment|October 10, 2025
Assessment of vitiligo in clinical practice: a cross-sectional survey among expertsJolien Duponselle, Marlide R Jukema, Albert Wolkerstorfer, et al.
Clinics in Dermatology|September 14, 2021
Learning from disease registries during a pandemic: Moving toward an international federation of patient registriesDmitri Wall, Raed Alhusayen, Bernd Arents, et al.
The Journal of Allergy and Clinical Immunology|October 19, 2020
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based studySatveer K Mahil, Nick Dand, Kayleigh J Mason, et al.
Pageof 3